| Detected | Trial | Change |
|---|---|---|
| 2026-08-13 | NCT06688435 A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in… |
Primary endpoint(s) modified |
| 2026-08-13 | NCT06688435 A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in… |
Enrollment increased: 50 -> 60 participants |
| 2026-08-13 | NCT06688435 A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in… |
Trial arms changed: 5 -> 7 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-11 | NCT07756996 Evaluation of Bioequivalence and Food Effect of a New Strength Formulation of Ammoxetine… | Phase 1 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06313086 | DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced Breast… | HER2-positive Breast Cancer | Recruiting |
| NCT06296706 | A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric… | Gastric Cancer | Recruiting |
| NCT05901935 | DP303c in Patients With HER2-positive Advanced Breast Cancer | HER2-positive Advanced Breast Cancer | Not Yet Recruiting |
| NCT06492941 | A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic… | Advanced Pancreatic Cancer | Not Yet Recruiting |
| NCT06771245 | A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine… | Mild-to-moderate Essential Hypertension | Not Yet Recruiting |
| NCT06827431 | The Research of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With… | Major Depressive Disorder (MDD) | Not Yet Recruiting |
| NCT06929325 | Sirolimus for Injection (Albumin-bound) Combined With Fulvestrant for HR+/HER2… | HR+/HER2- Advanced/Metastatic Breast Cancer | Not Yet Recruiting |
| NCT04668690 | Clinical Study of Mitoxantrone Hydrochloride Liposome Injection vs. Chidamide in Patients… | Peripheral T Cell Lymphoma | Active, Not Recruiting |
| NCT07163364 | A Study to Evaluate the Effects and Safety of Hydroxocobalamin in Participants With… | Methylmalonic Acidemia (MMA) | Not Yet Recruiting |
| NCT07623824 | A Phase III Clinical Trial to Evaluate the Efficacy and Safety of Octreotide Long-acting… | Diagnosed With Acromegaly, Currently in the Active Stage of the Disease | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT05761028 | A Study of CM310 in Subjects With Moderate to Severe Asthma | Moderate to Severe Asthma | Recruiting |
| NCT07165886 | Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in… | Gastroenteropancreatic Neuroendocrine Tumors | Recruiting |
| NCT06547333 | A Study of CM310 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease | Not Yet Recruiting |
| Phase 2 | |||
| NCT06505395 | A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection… | Gastrointestinal Neuroendocrine Pancreatic Tumor | Recruiting |
| NCT06947291 | Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound)… | Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors | Recruiting |
| NCT07418736 | A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive… | Chronic Obstructive Pulmonary Disease | Recruiting |
| NCT06525350 | A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and… | Locally Advanced/Recurrent or Distant Metastasized Non-small Cell Lung Cancer With MET Overexpression | Not Yet Recruiting |
| NCT06957379 | Sirolimus for Injection (Albumin-bound) in Combination With Endocrine Therapy for… | HR+/HER2- Advanced/Metastatic Breast Cancer | Active, Not Recruiting |
| NCT07083505 | A Study Comparing the Efficacy and Safety of HB1801 With Taxotere® in Advanced Breast… | Advanced Breast Cancer | Not Yet Recruiting |
| NCT07116824 | HB1801 Combined Treatment of HER2-positive Breast Cancer | HER2-positive Breast Cancer | Not Yet Recruiting |
| NCT07684287 | A Phase 2 Study of Sirolimus for Injection (Albumin-bound) in Patients With Progressive… | Epithelioid Hemangioendothelioma | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT05445154 | SKLB1028, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute… | Newly Diagnosed Acute Myeloid Leukemia (AML) | Recruiting |
| NCT07241936 | A Study of Sirolimus (Albumin-Bound) in Combination With Different ADCs Treatment of… | Advanced Solid Tumors | Recruiting |
| NCT05055791 | A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With… | Acute Myeloid Leukemia | Not Yet Recruiting |
| NCT06136988 | A Study of Docetaxel for Injection (Albumin-bound) and SG001 in Combination With… | Locally Advanced Unresectable Esophageal Squamous Carcinoma | Not Yet Recruiting |